Citigroup’s Akoya BioSciences AKYA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.21K | Sell |
931
-18,647
| -95% | -$24.2K | ﹤0.01% | 4645 |
|
|
2025
Q1 | $27.2K | Sell |
19,578
-29,209
| -60% | -$40.6K | ﹤0.01% | 4257 |
|
|
2024
Q4 | $112K | Buy |
48,787
+29,484
| +153% | +$67.5K | ﹤0.01% | 3937 |
|
|
2024
Q3 | $52.5K | Buy |
19,303
+13,506
| +233% | +$36.7K | ﹤0.01% | 4232 |
|
|
2024
Q2 | $13.6K | Buy |
5,797
+1,932
| +50% | +$4.52K | ﹤0.01% | 4342 |
|
|
2024
Q1 | $18.1K | Buy |
3,865
+447
| +13% | +$2.1K | ﹤0.01% | 4309 |
|
|
2023
Q4 | $16.7K | Buy |
3,418
+3,399
| +17,889% | +$16.6K | ﹤0.01% | 4289 |
|
|
2023
Q3 | $88 | Sell |
19
-5,397
| -100% | -$25K | ﹤0.01% | 4665 |
|
|
2023
Q2 | $40K | Buy |
+5,416
| New | +$40K | ﹤0.01% | 4077 |
|
|
2023
Q1 | – | Sell |
-121
| Closed | -$1.16K | – | 4718 |
|
|
2022
Q4 | $1.16K | Sell |
121
-131
| -52% | -$1.25K | ﹤0.01% | 4590 |
|
|
2022
Q3 | $3K | Sell |
252
-771
| -75% | -$9.18K | ﹤0.01% | 4556 |
|
|
2022
Q2 | $13K | Buy |
1,023
+526
| +106% | +$6.68K | ﹤0.01% | 4498 |
|
|
2022
Q1 | $5K | Sell |
497
-3,146
| -86% | -$31.7K | ﹤0.01% | 4975 |
|
|
2021
Q4 | $56K | Buy |
3,643
+2,745
| +306% | +$42.2K | ﹤0.01% | 4235 |
|
|
2021
Q3 | $13K | Buy |
898
+535
| +147% | +$7.75K | ﹤0.01% | 4636 |
|
|
2021
Q2 | $7K | Buy |
+363
| New | +$7K | ﹤0.01% | 5082 |
|